Taxol synergizes with antioxidants in inhibiting hormal refractory prostate cancer cell growth

Greenlee, 2000, Cancer statistics, CA Cancer J Clin, 50, 7, 10.3322/canjclin.50.1.7 Pu, 2000, Prostate cancer in Taiwan: Epidemiology and risk factors, Int J Androl, 23, 34, 10.1046/j.1365-2605.2000.00012.x Chen, 2004, Dietary chemopreventive compounds and ARE/EpRE signaling, Free Rad Biolo Med, 36, 1505, 10.1016/j.freeradbiomed.2004.03.015 Namiecinski, 2004, Cytotoxicity, cytoprotection, and neurotoxicity of novel deprenyl-related propargylamines, stable nitroxide free radicals, in vitro and in vivo, In Vivo, 18, 171 Schreck, 1992, Dithiocarbamates as potent inhibitors of nuclear factor-kappa B activation in intact cells, J Exp Med, 175, 1181, 10.1084/jem.175.5.1181 Chiner, 1999, Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBP β, Nutr Med, 11, 1233 Buchler, 2003, Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid, Pancreas, 26, 264, 10.1097/00006676-200304000-00010 Sasamura, 2004, Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma, Urology, 64, 389, 10.1016/j.urology.2004.03.045 McDonnell, 2004, Improvement in efficacy of chemoradiotherapy by addition of an antiangiogenic agent in a murine tumor model, J Surg Res, 116, 19, 10.1016/j.jss.2003.09.014 Gupta, 2004, Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor κ B and induction of apoptosis, Oncogene, 23, 2507, 10.1038/sj.onc.1207353 Lambert, 2003, Mechanisms of cancer prevention by tea constituents, J Nutr, 133, 3262, 10.1093/jn/133.10.3262S Fleshner, 2001, Antioxidant dietary supplement: Rational and current status as chemopreventive agent for prostate cancer, Urology, 57, 90, 10.1016/S0090-4295(00)00949-3 Chou, 1976, Derivation and properties of Michaelis-Menton type and Hill type equations for reference ligands, J Theor Biol, 59, 253, 10.1016/0022-5193(76)90169-7 Chou, 1984, Quantitative analysis of dose–effect relationships: The combined effects of multiple drugs or enzyme inhibitors, Adv Enz Regul, 22, 27, 10.1016/0065-2571(84)90007-4 Osswald, 1990, Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210, J Cancer Res Clin Oncol, 116, 448, 10.1007/BF01612992 Chen, 2001, Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate, Oncogene, 20, 367, 10.1038/sj.onc.1204105 Siddiqui, 2004, Modulation of phosphatidylinositol-3-kinase/protein kinase B and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells, J Cell Biochem, 91, 232, 10.1002/jcb.10737 Bektic, 2005, Molecular effects of the isoflavonoid genistein in prostate cancer, Clin Prostate Cancer, 4, 124, 10.3816/CGC.2005.n.021 Touny, 2006, Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein, Prostate, 66, 1542, 10.1002/pros.20495 Chou, 1988, Generalized equations for the analysis of inhibitions of Michaelis-Menton and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors, Eur J Biochem, 115, 207, 10.1111/j.1432-1033.1981.tb06218.x